"mRNA's manufacturing bottleneck became its own market."
Demand for lipid nanoparticle formulation outpaced in-house capacity at most biotech developers, which is exactly the gap CDMOs exist to fill. Capacity, not chemistry, is the constraint here.
Read the report behind this view
Lipid Nanoparticles CDMO Market - Global Opportunity Analysis and Industry Forecast (2026-2036)